Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis

Background Response to ursodeoxycholic acid (UDCA) in primary biliary cholangitis (PBC) has been traditionally assessed 1 to 2 years after treatment initiation. With the development of new drugs, some patients may benefit from an earlier introduction of second-line therapies. Aims This study aims to...

Full description

Saved in:
Bibliographic Details
Published inDigestive diseases and sciences Vol. 68; no. 2; pp. 514 - 520
Main Authors Cançado, Guilherme Grossi Lopes, Couto, Cláudia Alves, Terrabuio, Debora Raquel Benedita, Cançado, Eduardo Luiz Rachid, Villela-Nogueira, Cristiane Alves, Ferraz, Maria Lucia Gomes, Braga, Michelle Harriz, Nardelli, Mateus Jorge, Faria, Luciana Costa, de Faria Gomes, Nathalia Mota, Oliveira, Elze Maria Gomes, Rotman, Vivian, Oliveira, Maria Beatriz, da Cunha, Simone Muniz Carvalho Fernandes, Cunha-Silva, Marlone, Mendes, Liliana Sampaio Costa, Ivantes, Claudia Alexandra Pontes, Codes, Liana, de Almeida e Borges, Valéria Ferreira, de Lima Pace, Fabio Heleno, Pessoa, Mario Guimarães, Guedes, Laura Vilar, Signorelli, Izabelle Venturini, Coral, Gabriela Perdomo, Levy, Cynthia, Bittencourt, Paulo Lisboa
Format Journal Article
LanguageEnglish
Published New York Springer US 01.02.2023
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…